| Global epidemiology of NAFLD-related HCC: trends, predictions, risk factors and prevention DQ Huang, HB El-Serag, R Loomba Nature reviews Gastroenterology & hepatology 18 (4), 223-238, 2021 | 1512 | 2021 |
| Epidemiology of COVID‐19: A systematic review and meta‐analysis of clinical characteristics, risk factors, and outcomes J Li, DQ Huang, B Zou, H Yang, WZ Hui, F Rui, NTS Yee, C Liu, ... Journal of medical virology 93 (3), 1449-1458, 2021 | 934 | 2021 |
| Global prevalence, incidence, and outcomes of non-obese or lean non-alcoholic fatty liver disease: a systematic review and meta-analysis Q Ye, B Zou, YH Yeo, J Li, DQ Huang, Y Wu, H Yang, C Liu, LY Kam, ... The lancet Gastroenterology & hepatology 5 (8), 739-752, 2020 | 775 | 2020 |
| 2019 Global NAFLD prevalence: a systematic review and meta-analysis MH Le, YH Yeo, X Li, J Li, B Zou, Y Wu, Q Ye, DQ Huang, C Zhao, ... Clinical Gastroenterology and Hepatology 20 (12), 2809-2817. e28, 2022 | 560 | 2022 |
| Global epidemiology of cirrhosis—aetiology, trends and predictions DQ Huang, NA Terrault, F Tacke, LL Gluud, M Arrese, E Bugianesi, ... Nature reviews Gastroenterology & hepatology 20 (6), 388-398, 2023 | 463 | 2023 |
| The global burden of metabolic disease: Data from 2000 to 2019 NWS Chew, CH Ng, DJH Tan, G Kong, C Lin, YH Chin, WH Lim, ... Cell metabolism 35 (3), 414-428. e3, 2023 | 403 | 2023 |
| Changing global epidemiology of liver cancer from 2010 to 2019: NASH is the fastest growing cause of liver cancer DQ Huang, AG Singal, Y Kono, DJH Tan, HB El-Serag, R Loomba Cell metabolism 34 (7), 969-977. e2, 2022 | 357 | 2022 |
| Global incidence and prevalence of nonalcoholic fatty liver disease MLP Teng, CH Ng, DQ Huang, KE Chan, DJH Tan, WH Lim, JD Yang, ... Clinical and molecular hepatology 29 (Suppl), S32, 2022 | 337 | 2022 |
| Global epidemiology of alcohol-associated cirrhosis and HCC: trends, projections and risk factors DQ Huang, P Mathurin, H Cortez-Pinto, R Loomba Nature reviews Gastroenterology & hepatology 20 (1), 37-49, 2023 | 297 | 2023 |
| Global burden of hepatitis B virus: current status, missed opportunities and a call for action YC Hsu, DQ Huang, MH Nguyen Nature reviews Gastroenterology & hepatology 20 (8), 524-537, 2023 | 273 | 2023 |
| Clinical characteristics, surveillance, treatment allocation, and outcomes of non-alcoholic fatty liver disease-related hepatocellular carcinoma: a systematic review and meta … DJH Tan, CH Ng, SY Lin, XH Pan, P Tay, WH Lim, M Teng, N Syn, G Lim, ... The Lancet Oncology 23 (4), 521-530, 2022 | 240 | 2022 |
| Global prevalence and clinical characteristics of metabolic-associated fatty liver disease: a meta-analysis and systematic review of 10 739 607 individuals KE Chan, TJL Koh, ASP Tang, J Quek, JN Yong, P Tay, DJH Tan, WH Lim, ... The Journal of Clinical Endocrinology & Metabolism 107 (9), 2691-2700, 2022 | 197 | 2022 |
| An observational data meta-analysis on the differences in prevalence and risk factors between MAFLD vs NAFLD GEH Lim, A Tang, CH Ng, YH Chin, WH Lim, DJH Tan, JN Yong, J Xiao, ... Clinical Gastroenterology and Hepatology 21 (3), 619-629. e7, 2023 | 190 | 2023 |
| Natural history and hepatocellular carcinoma risk in untreated chronic hepatitis B patients with indeterminate phase DQ Huang, X Li, MH Le, AK Le, YH Yeo, HN Trinh, J Zhang, J Li, C Wong, ... Clinical Gastroenterology and Hepatology 20 (8), 1803-1812. e5, 2022 | 119 | 2022 |
| Mortality outcomes by fibrosis stage in nonalcoholic fatty liver disease: a systematic review and meta-analysis CH Ng, WH Lim, GEH Lim, DJH Tan, N Syn, MD Muthiah, DQ Huang, ... Clinical Gastroenterology and Hepatology 21 (4), 931-939. e5, 2023 | 108 | 2023 |
| Patterns in cancer incidence among people younger than 50 years in the US, 2010 to 2019 B Koh, DJH Tan, CH Ng, CE Fu, WH Lim, RW Zeng, JN Yong, JH Koh, ... JAMA network open 6 (8), e2328171-e2328171, 2023 | 97 | 2023 |
| Global prevalence of non-alcoholic fatty liver disease in type 2 diabetes mellitus: an updated systematic review and meta-analysis EEL Cho, CZ Ang, J Quek, CE Fu, LKE Lim, ZEQ Heng, DJH Tan, WH Lim, ... Gut 72 (11), 2138-2148, 2023 | 95 | 2023 |
| Hepatocellular carcinoma surveillance—utilization, barriers and the impact of changing aetiology DQ Huang, AG Singal, F Kanwal, P Lampertico, M Buti, CB Sirlin, ... Nature Reviews Gastroenterology & Hepatology 20 (12), 797-809, 2023 | 93 | 2023 |
| Fibrosis progression rate in biopsy-proven nonalcoholic fatty liver disease among people with diabetes versus people without diabetes: a multicenter study DQ Huang, LA Wilson, C Behling, DE Kleiner, KV Kowdley, S Dasarathy, ... Gastroenterology 165 (2), 463-472. e5, 2023 | 93 | 2023 |
| Global burden of liver cancer in males and females: changing etiological basis and the growing contribution of NASH DJH Tan, VW Setiawan, CH Ng, WH Lim, MD Muthiah, EX Tan, YY Dan, ... Hepatology 77 (4), 1150-1163, 2023 | 91 | 2023 |
